Award
Delivery Order #SPE2DR26FM66E
Short-Term Delivery Order for Pharmaceutical Product by AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$136.40
Ceiling
$136.40
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26FM66E
NAICS
424210
This award represents a definitive delivery order contract for pharmaceutical products, specifically butalbital-acetaminophen-caffeine tablets, facilitated under an existing indefinite delivery vehicle (IDV) contract held by AmerisourceBergen Drug Corporation. AmerisourceBergen, a leading pharmaceutical distributor, is responsible for supplying essential medications that support public health initiatives. The contract's significance lies in ensuring timely and reliable delivery of critical pharmaceutical products to healthcare providers, thereby sustaining healthcare operations. The scope involves the provision and delivery of a specified pharmaceutical formulation within a short performance window. The award was made as a follow-on order under a pre-established IDV contract, indicating a streamlined procurement process rather than a separate competitive bid. The performance is scheduled over a brief timeframe, reflecting the immediate fulfillment of specific product needs. The contract executes within the existing broader framework that extends through 2036, emphasizing AmerisourceBergen's ongoing role as a key pharmaceutical supplier to the agency.
Description
4571085429!BUTALB-ACETAMIN-CAFF 50-325-40 500S